Injective vs Kinetiq

Compare Injective and Kinetiq on TVL, fees, revenue and activity to understand how these projects stack up.

Injective Perps is the perpetual futures market of Injective, a layer 1 blockchain optimized for finance. Trading runs on Injective's native onchain order book module, which offers fully onchain matching and settlement, front-running resistance through frequent batch auctions and very low fees. Markets cover major crypto assets as well as real-world assets such as equities, commodities and forex, and the shared liquidity layer is used by multiple trading front-ends built on Injective. Part of the fees feeds the INJ burn auction.
View Full Page
$900.76M
Kinetiq is a non-custodial liquid staking protocol built natively on Hyperliquid L1. Users stake HYPE and receive kHYPE, a liquid, yield-accruing representation usable across the Hyperliquid DeFi ecosystem. Behind the scenes, StakeHub — Kinetiq’s autonomous validator scoring and delegation system — routes stake to the highest-performing validators to maximise yield and reinforce network security. kHYPE grows in value automatically through validator rewards, requires no claiming, and remains fully composable for lending, liquidity provision and advanced yield strategies. Kinetiq’s architecture emphasises security through multi-layered safeguards, multiple independent audits and a $5M bug bounty. The protocol also offers iHYPE, a compliant, institution-ready staking solution. With over a billion dollars staked, Kinetiq powers scalable, efficient and integrated liquid staking for the entire Hyperliquid ecosystem.
View Full Page

Key Metrics Comparison

Injective
TVL
N/A
24h Volume
$4.43M
24h Fees
N/A
24h Revenue
N/A
30d Fees
N/A
30d Revenue
N/A
7d TVL Change
N/A
Dominance
0.00%
Kinetiq
TVL
$900.76M
24h Volume
$1.75M
24h Fees
$49.6K
24h Revenue
$4.8K
30d Fees
$1.7M
30d Revenue
$183.9K
7d TVL Change
-5.82%
Dominance
1.00%

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

TVL Share

Share of combined TVL

TVL Share
Injective
1.0%
Kinetiq
1.0%

Volume Share

Share of combined 24h volume

Volume Share
Injective
71.6%
Kinetiq
28.4%

Fees Share

Share of combined 24h fees

Fees Share
Injective
1.0%
Kinetiq
1.0%

Revenue Share

Share of combined 24h revenue

Revenue Share
Injective
1.0%
Kinetiq
1.0%

7d TVL Performance

TVL change over last 7 days

7d TVL Performance
Injective
N/A
Kinetiq
-5.82%

Dominance

Market dominance by TVL

Dominance
Injective
0.0%
Kinetiq
1.0%